Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Peter Rueegg"'
Autor:
David L. Earnest, Dongham Luo, Victor Shi, Angeli Dogra, Johnson L. Thistle, Robert S. Fisher, Christoph Beglinger, Peter Rueegg, James Novick, William D. Chey, Anthony Lembo, Patrick O'Kane
Publikováno v:
The American journal of gastroenterology. 99(7)
OBJECTIVE: Tegaserod is a 5-HT4 receptor partial agonist that increases peristaltic activity of the intestinal tract. It is approved for the treatment of patients with irritable bowel syndrome with constipation (IBS-C). IBS is a chronic gastrointesti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9ec5be8c6b47807b404c66c05356110
https://pubmed.ncbi.nlm.nih.gov/15233676
https://pubmed.ncbi.nlm.nih.gov/15233676
Autor:
Angeli Dogra, Johnson L. Thistle, Peter Rueegg, Victor Shi, James Novick, David L. Earnest, Don Luo, Robert S. Fisher, William D. Chey, Patrick O'Kane, Anthony Lembo
Publikováno v:
American Journal of Gastroenterology. 98:S270-S271
Purpose: Tegaserod (T), a 5-HT4 receptor partial agonist that increases peristaltic activity of intestinal muscle, is used to treat irritable bowel syndrome with constipation (IBS-C). Whether T effects biliary tract motility is not known. The goal of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c81ef7553ffe9b9dd3737bace4df5474
https://doi.org/10.1111/j.1572-0241.2003.08552.x
https://doi.org/10.1111/j.1572-0241.2003.08552.x